Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epilepsy, Immune Dysfunction and Risk of Infection Study - A Prospective Cohort Study of Immune Dysfunction and Infection Risk With Epilepsy

NCT07903168 is registered in ClinicalTrials.gov with University of Aberdeen as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07903168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Epilepsy, Immune Dysfunction and Risk of Infection Study - A Prospective Cohort Study of Immune Dysfunction and Infection Risk With Epilepsy
Lead sponsor
University of Aberdeen
Phase
Observational
Overall status
Recruiting
Start date
November 4, 2026
Completion date
May 31, 2038
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiepileptic drugs, epilepsy, immune dysfunction, infection

Arms

As registered; 2 arms.

  • Exposed Antiepileptic Drug

    Individuals taking antiseizure medications

  • Unexposed

    Individuals not taking antiseizure medications

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Infections During a 10 year period from the time of enrolment

    Clinically significant rates of infection (community antimicrobial prescriptions or hospital admissions with infection)

Lead sponsor's other trials

University of Aberdeen, most recent start first.

Similar trials

Same condition (Epilepsy) and phase, most recent start first.